Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_assertion type Assertion NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_head.
- NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_assertion description "[Retinoic acid receptor alpha (RARA) and other target sequences at 17p11.2 often represent the amplicons expressed in breast cancer, not in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_provenance.
- NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_assertion evidence source_evidence_literature NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_provenance.
- NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_assertion SIO_000772 20804918 NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_provenance.
- NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_assertion wasDerivedFrom befree-20140225 NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_provenance.
- NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_assertion wasGeneratedBy ECO_0000203 NP321810.RAuO0dYTr9r0XxeSMaIYg5eNQxmpNl-8dB-vNFHwNklHo130_provenance.